カテゴリ： MarketLine, アメリカ, 企業調査

Myriad Genetics, Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4299
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：51
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Myriad Genetics, Inc. (Myriad or ‘the company’) is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. It operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has operations in the US and Europe. The company is headquartered in Salt Lake City, Utah, the US.

Scope

- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments
- Intelligence on Myriad Genetics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Myriad Genetics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Myriad Genetics, Inc.: Company Overview
Myriad Genetics, Inc.: Overview and Key Facts
Myriad Genetics, Inc.: Overview
Myriad Genetics, Inc.: Key Facts
Myriad Genetics, Inc.: Key Employees
Myriad Genetics, Inc.: Key Employee Biographies
Myriad Genetics, Inc.: Major Products and Services
Myriad Genetics, Inc.: Company History
Myriad Genetics, Inc.: Management Statement
Myriad Genetics, Inc.: Locations and Subsidiaries
Myriad Genetics, Inc.: Key Competitors
Myriad Genetics, Inc.: Company Analysis
Myriad Genetics, Inc.: Business Description
Myriad Genetics, Inc.: SWOT Analysis
Myriad Genetics, Inc.: SWOT Overview
Myriad Genetics, Inc.: Strengths
Myriad Genetics, Inc.: Weaknesses
Myriad Genetics, Inc.: Opportunities
Myriad Genetics, Inc.: Threats
Myriad Genetics, Inc.: Corporate Financial Deals Activity
Myriad Genetics, Inc.: Financial Deals Overview
Myriad Genetics, Inc.: Targets and Partners
Myriad Genetics, Inc.: Top Deals 2016 – 2020YTD*
Myriad Genetics, Inc.: Advisors
Myriad Genetics, Inc.: Top Legal Advisors
Myriad Genetics, Inc.: Top Financial Advisors
Myriad Genetics, Inc.: Mergers and Acquisitions
Myriad Genetics, Inc.: Capital Raising
Myriad Genetics, Inc.: Partnership
Myriad Genetics, Inc.: Recent Developments
Myriad Genetics, Inc.: News and Events Summary
Myriad Genetics, Inc.: Contracts
Myriad Genetics, Inc.: Corporate Governance
Myriad Genetics, Inc.: Financial Performance
Myriad Genetics, Inc.: Market Developments
Myriad Genetics, Inc.: Regulatory and Legal Events
Myriad Genetics, Inc.: Research & Development
Myriad Genetics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Myriad Genetics, Inc.: Key Facts
Table 2: Myriad Genetics, Inc.: Key Employees
Table 3: Myriad Genetics, Inc.: Company History
Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries
Table 5: Myriad Genetics, Inc.: Key Competitors
Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Myriad Genetics, Inc.: Targets and Partners
Table 10: Myriad Genetics, Inc.: Top Deals 2016 - 2020YTD*
Table 11: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Myriad Genetics, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Myriad Genetics, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: Myriad Genetics, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: Myriad Genetics, Inc.: News and Events Summary
Table 20: Myriad Genetics, Inc.: Contracts
Table 21: Myriad Genetics, Inc.: Corporate Governance
Table 22: Myriad Genetics, Inc.: Financial Performance
Table 23: Myriad Genetics, Inc.: Market Developments
Table 24: Myriad Genetics, Inc.: Regulatory and Legal Events
Table 25: Myriad Genetics, Inc.: Research & Development
Table 26: Myriad Genetics, Inc.: Strategy and Operations

★海外企業調査レポート[Myriad Genetics, Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Navitor Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Navitor Pharmaceuticals Inc (Navitor Pharmaceuticals) is a biopharmaceutical company that develops medicines by targeting cellular nutrient signaling pathways. The company harnesses its proprietary drug discovery platform to develop selective modulators of the mTORC1 pathway. It develops mTO …
  • Southern Copper Corporation：企業の戦略・SWOT・財務情報
    Southern Copper Corporation - Strategy, SWOT and Corporate Finance Report Summary Southern Copper Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MLM Biologics Inc：企業の製品パイプライン分析
    Summary MLM Biologics Inc (MLM Biologics) operates as a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full …
  • Ems-Chemie Holding AG (EMSN)：企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie) is a chemical company that manufactures and markets high performance polymers and specialty chemicals. The company's products include bonding products, polyamides, damping systems, sealants, coating products, thermoplastic material, technical fibers, and te …
  • HC Slingsby Plc：企業の戦略・SWOT・財務情報
    HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report Summary HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Courtagen Life Sciences Inc-医療機器分野：企業M&A・提携分析
    Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equip …
  • Praxair Inc (PX)：石油・ガス：M&Aディール及び事業提携情報
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company produces atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and buil …
  • Marsh & McLennan Companies Inc：企業の戦略・SWOT・財務分析
    Marsh & McLennan Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Marsh & McLennan Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sanwa Kagaku Kenkyusho Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Sanwa Kagaku Kenkyusho Co Ltd (Sanwa), a subsidiary of Suzuken Co Ltd is a contract manufacturing company that conducts research, manufactures and commercializes of pharmaceutical drugs for treating diagnostics, healthcare products, and medical and nursing care nutritionals. The company also …
  • Barclaycard：企業の戦略・SWOT・財務分析
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Novelis Inc：企業の戦略・SWOT・財務分析
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kadimastem Ltd (KDST)：企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Alps Alpine Co Ltd (6770)：企業の財務・戦略的SWOT分析
    Alps Alpine Co Ltd (6770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • American Packaging Corporation：企業の戦略・SWOT・財務情報
    American Packaging Corporation - Strategy, SWOT and Corporate Finance Report Summary American Packaging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kazanorgsintez (KZOS)：企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • P. H. Glatfelter Co (GLT)：企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Probi AB (PROB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Probi AB (Probi) is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and immune system. It distributes its products to l …
  • Corporation Bank：企業の戦略・SWOT・財務情報
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MAN SE：企業の戦略・SWOT・財務分析
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Orkuveita Reykjavikur：電力：M&Aディール及び事業提携情報
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆